Lilly China, Tencent, and DXY Announce Strategic Collaboration in Diabetes Management

(Shanghai, China, February 13, 2017) Eli Lilly China, Tencent, and DXY announced an industry-exclusive strategic partnership in the field of diabetes to jointly develop and launch a diabetes care and support initiative—the “Eli Lilly Diabetes Care Excellence Program.”

This project aims to enable physicians and patients to better manage diabetes and achieve treatment goals through internet-based technologies, disease education, and services. It will provide patients with advanced blood glucose monitoring devices, educational tools, and professional patient care services, while delivering real-time, precise patient data to physicians and patients’ family members and friends. This collaborative model is the first of its kind in China and unprecedented in scale, pioneering a new diabetes management paradigm forged by a strategic alliance among multinational pharmaceutical companies, internet firms, and physician academic service platforms.

Diabetes is a major global public health issue that has imposed substantial physiological and economic burdens on patients, their families, local governments, and communities.China currently has over 110 million patients with diabetes, accounting for nearly 10% of the total adult population. This figure is projected to increase by 30% over the next 20 years.Among these diagnosed and treated patients, fewer than one-third of those with diabetes achieved target blood glucose levels. Blood glucose monitoring and the proper use of insulin are crucial in blood glucose control and disease management.

Anders Hedberg, President of Eli Lilly China, stated, “We are delighted to jointly launch the groundbreaking Eli Lilly Diabetes Care Program with Tencent and DXY, to better support physicians and patients in their fight against diabetes. As a company with nearly a century of experience in the field of diabetes, we have always been committed to our mission of helping patients achieve better treatment outcomes. Collaborating with China’s leading internet technology companies and the country’s largest and most trusted physician social platform enables us to make further strides toward fulfilling this mission.”

Wu Bo, General Manager of Tencent’s TengAi Medical, stated, “This collaboration is jointly undertaken by Eli Lilly, Tencent, and DXY.”The project fully leverages the expertise and experience of the three parties in diabetes treatment, patient education, physician relations, digital technology, and internet technology to advance the implementation of care services for patients with diabetes., aiming to provide diabetic patients with a novel chronic disease management solution and experience, helping them better control their condition. ”

Currently, Tencent has adopted “connecting everything” as its strategic objective, leveraging internet technologies to meet user needs in communication, information, lifestyle, entertainment, and finance. This approach has profoundly influenced and transformed the communication patterns and daily habits of hundreds of millions of internet users, while opening up broader application prospects for China’s internet industry.

As the most influential academic service platform for physicians in the medical internet sector, DXY has accumulated extensive experience in physician education over the past 16 years, built robust capabilities, and earned widespread trust among the medical community. Within the current healthcare system, physicians undoubtedly play the most critical role in advancing patient education.This project provides physicians with more convenient and rapid access to data, thereby facilitating improved patient disease management.。

Since its establishment in 2000, DXY has amassed over 4.8 million professional users in the biopharmaceutical sector, including 2 million physicians and 2.8 million professionals in life sciences-related fields.

In the field of public health, DXY also provides mass consumers with rich digital platforms and health-related content, having amassed tens of millions of users. Meanwhile, DXY’s offline clinics have been established in Hangzhou and Fuzhou, with plans to expand into more cities.

“We aim to collaborate with physicians to provide patients with professional disease education and management,” said Li Tiantian, founder of DXY. “At the same time, patient management is a long-term and arduous endeavor. We need to join forces with partners across the health industry to deliver trustworthy products and services to patients. In this process, we are honored to work alongside Eli Lilly and Tencent, leveraging an innovative digital platform to connect medical devices with professional services, thereby helping patients with diabetes manage their condition and improve their quality of life.”

It is understood that, as a global leader in the healthcare industry, Eli Lilly has been committed to rewarding patients with innovation and caring for lives. For over 140 years since its founding, Eli Lilly has consistently adhered to the philosophy of providing patients with the highest quality medicines using the latest technologies, a principle that aligns with the commitment made by the company’s founder, Colonel Eli Lilly.

Lilly’s Diabetes Care Excellence Program leverages a novel digital approach to efficiently connect patients, physicians, and professional caregivers, thereby enhancing the diabetes management experience. With a long-standing history and leading expertise in diabetes treatment, Lilly has actively participated in government efforts to improve disease management and will continue to support more Chinese patients with diabetes through the “Lilly Diabetes Care Excellence Program.” Through the launch of this innovative patient care initiative, Lilly, Tencent, and DXY are collaborating to support the government and healthcare institutions in better assisting Chinese patients with diabetes.